Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-25-002112
Filing Date
2025-03-04
Accepted
2025-03-04 07:48:33
Documents
7
Effectiveness Date
2025-03-04

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20250304xs8.htm S-8 113968
2 EX-5.1 tmb-20250304xex5d1.htm EX-5.1 15628
3 EX-23.1 tmb-20250304xex23d1.htm EX-23.1 1865
4 EX-FILING FEES tmb-20250304xexfees.htm EX-FILING FEES 32005
5 GRAPHIC tmb-20250304xex5d1002.jpg GRAPHIC 8986
6 GRAPHIC tmb-20250304xex5d1003.jpg GRAPHIC 5100
7 GRAPHIC tmb-20250304xex5d1005.jpg GRAPHIC 699
  Complete submission text file 0001558370-25-002112.txt   185382
Mailing Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540 646-885-8505
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285527 | Film No.: 25701578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)